Alexandra Drakaki

University of California, Los Angeles

Papers

1

Total Citations

64

H-Index

1

About

Dr. Alexandra Drakaki is a distinguished urologic oncologist whose research centers on the surgical management and outcomes of genitourinary malignancies, with a particular focus on upper tract urothelial carcinoma (UTUC) and renal cell carcinoma. Her most cited work, a 2017 study examining the role of surgical approach on lymph node dissection yield and survival in UTUC patients (64 citations), has significantly advanced clinical understanding of how minimally invasive techniques impact oncologic efficacy. Dr. Drakaki’s contributions bridge the gap between surgical precision and patient survival, demonstrating that lymph node dissection quality—not just surgical approach—is a critical determinant of outcomes. Her research has influenced guidelines for UTUC management, emphasizing the importance of standardized lymphadenectomy. With a growing body of work cited by peers worldwide, Dr. Drakaki continues to shape evidence-based practices in urologic oncology, advocating for tailored surgical strategies that improve both staging accuracy and long-term prognosis. Her dedication to refining surgical protocols underscores her role as a leader in optimizing care for patients with complex urologic cancers.

Research Focus

Key Achievements

1
H-Index
1
Papers
64
Total Citations
64
Avg Citations/Paper
🏆 Most Cited Paper
Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma
64 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of California, Los Angeles

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago